The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA.
暂无分享,去创建一个
[1] R. Schwartz,et al. Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. , 1983, The New England journal of medicine.
[2] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[3] G. Hughes,et al. Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. , 1982, Annals of the rheumatic diseases.
[4] T. Koike,et al. Specificity of mouse hybridoma antibodies to DNA. , 1982, Immunology letters.
[5] G. Hughes,et al. Radioimmunoassay profile of antiglobulins in connective tissue diseases: elevated level of IgA antiglobulin in systemic sicca syndrome. , 1981, Clinical and experimental immunology.
[6] R. Schwartz,et al. Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids , 1981, The Journal of experimental medicine.
[7] S. Shapiro,et al. Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. , 1980, The Journal of clinical investigation.
[8] N. Radford,et al. POSSIBLE RELATIONSHIP BETWEEN LUPUS INHIBITOR AND RECURRENT ABORTION IN YOUNG WOMEN , 1980, The Lancet.
[9] D. Gladman,et al. Venous syndromes and pulmonary embolism in systemic lupus erythematosus. , 1980, Annals of the rheumatic diseases.
[10] S. Rapaport,et al. Thrombosis in patients with the lupus anticoagulant. , 1980, Annals of internal medicine.
[11] P. Mannucci,et al. The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant. , 2009, Scandinavian journal of haematology.
[12] Y. Sultan,et al. Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage. , 1979, The Journal of laboratory and clinical medicine.
[13] M. Reichlin,et al. The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases. , 1979, The Journal of rheumatology.
[14] E. Jaffe,et al. A clinical study of the lupus anticoagulant. , 1976, Blood.
[15] L. Horton,et al. CHRONIC NON-SPECIFIC ENDOMETRITIS , 1976, The Lancet.
[16] I. Nilsson,et al. Intrauterine death and circulating anticoagulant ("antithromboplastin"). , 2009, Acta medica Scandinavica.
[17] N. Talal,et al. IgM and IgG antibodies to DNA, RNA, and DNA:RNA in systemic lupus erythematosus. , 1975, Clinical immunology and immunopathology.
[18] H. Kronenberg,et al. STUDIES ON PHOSPHOLIPIDS IN THE ACTION OF A LUPUS COAGULATION INHIBITOR , 1975, Pathology.
[19] M. Guarnieri,et al. A DNA antigen that reacts with antisera to cardiolipin. , 1974, Biochemical and biophysical research communications.
[20] D. Doniach,et al. A collagen disorder of the nervous system presenting as multiple sclerosis. , 1972, Brain : a journal of neurology.
[21] G. L. Noel,et al. Character of anti-DNA antibodies in systemic lupus erythematosus. , 1971, Clinical and experimental immunology.
[22] D. Estes,et al. THE NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSIS , 1971, Medicine.
[23] Y. Et,et al. Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus. , 1965 .
[24] S. Nojima,et al. The specificity of cardiolipin in the serological reaction. , 1965, Journal of biochemistry.
[25] E. Bowie,et al. THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS. , 1963, The Journal of laboratory and clinical medicine.
[26] D. Jackson,et al. CIRCULATING ANTICOAGULANTS: A STUDY OF 40 CASES AND A REVIEW OF THE LITERATURE , 1961, Medicine.
[27] A. Loeliger,et al. Prothrombin as Co-Factor of the Circulating Anticoagulant in Systemic Lupus Erythematosus? , 1959, Thrombosis and Haemostasis.
[28] I. Nilsson,et al. Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases. , 1957, The Journal of laboratory and clinical medicine.
[29] P. Frick,et al. Acquired circulating anticoagulants in systemic collagen disease; auto-immune thromboplastin deficiency. , 1955, Blood.